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Methods: We have reviewed our experience in38 patients with adenoid cystic 
carcinoma of the upper airway seen between 1963 and 1995. The mean age 
was 44.8 years (15 to 80 years) with a male/female ratio of 1:1.1. Thirty-two 
of the 38 patients were treated by resection and reconstruction (primary 
anastomosis 28; Marlex mesh prosthesis 4). Twenty-six of the 32 patients 
undergoing resection received adjuvant radiotherapy. Six patients with 
unresectable tumors were treated primarily with radiotherapy only. Results: 
Pathologic examination revealed local invasion beyond the wall of the 
trachea in all patients. In a majority, microscopic extension was found in 
submucosal nd perineural lymphatics, well beyond the grossly visible or 
palpable limits of the tumor. Lymphatic metastases were relatively uncom- 
mon, occurring in only five of 32 (19%) patients undergoing resection. 
Metachronous hematogenous metastases occurred in 17 of 38 patients 
(44%). Thirteen of these 38 patients (33%) had pulmonary metastases. 
Sixteen of 32 resections were complete and potentially curative. There were 
two deaths within 30 days of operation. The mean survival in the 14 patients 
undergoing complete resection was 9.8 years (12 months to 29 years). 
Sixteen of 32 resections were incomplete (residual tumor at the airway 
margin on final pathologic examination), with one operative death occur- 
ring in this group. The mean survival in the 15 surviving patients was 7.5 
years (4 months to 21 years). Six patients were treated with primary 
radiation only and had a mean survival of 6.2 years (2 months to 14.3 
years). In the patients with pulmonary metastases, mean survival was 37 
months (4 months to 7 years) from the time of diagnosis of the pulmonary 
metastasis until their death. Conclusion: Adenoid cystic carcinoma of the 
upper airway is a rare tumor, which is locally invasive and frequently 
amenable to resection. Although late local recurrence after resection is a 
feature of this tumor (up to 29 years), excellent long-term palliation is 
commonly achieved after both complete and incomplete resection. There 
was a small difference in survival between patients having complete and 
incomplete resection. Long periods of control can be obtained with radio- 
therapy alone. The best results, in this series of patients, were obtained by 
resection. Adjuvant radiotherapy is assumed to favorably influence sur- 
vival. (J Thorac Cardiovasc Surg 1996;112:1522-32) 
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T he incidence of primary tracheal tumors is less than 0.2 per 100,000 persons per year, with a 
prevalence of 1 per 15,000 autopsies. Tracheal cancer 
causes less than 0.1% of cancer deaths, x Squamous cell 
carcinoma nd adenoid cystic carcinoma re the most 
frequent histologic types, accounting for approxi- 
mately two-thirds of primary neoplasms of the air- 
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Table I. Treatment of 38 patients with adenoid 
cystic carcinoma of the upper airway 
No. of 
patients 
Primary resection and reconstruction 32 
Primary anastomosis 29 
Prosthetic reconstruction (Marlex mesh) 3 
Subsequent local recurrence r sected 3 
Primary radiotherapy only 6 
Subsequent local recurrence r sected 2 
way. 2-7 The clinical and pathologic features of adenoid 
cystic carcinoma of the trachea were first reported in 
1859 by Billroth. s Few centers throughout he world 
have accumulated significant patient numbers to re- 
port results of management of this tumor. 2-9 
Dur ing a 32-year per iod from 1963 to 1995, 38 
consecutive patients were seen by our service with a 
diagnosis of pr imary adenoid cystic carc inoma of the 
airway. Their  management  and fol low-up are re- 
ported.  
Patients and methods 
We retrospectively reviewed the charts of 38 consecu- 
tive patients with adenoid cystic carcinoma of the airway 
who were referred to the Toronto Hospital. Follow-up 
data were complete in all 38 patients. Survival was calcu- 
lated by the Kaplan-Meier actuarial method. Survival 
curves were compared by means of the log-rank test. 
Continuous data were analyzed by two-tailed t tests and 
expressed as the mean _+ standard eviation. Statistically 
significant difference is defined as a p value -< 0.05. 
Clinical presentation. Of the 38 patients, 18 were male 
and 20 female. The mean age at presentation was 45 years 
(15 to 80 years). There was frequently a long interval 
between the onset of symptoms and diagnosis. This delay 
is understandable b cause the plain chest radiograph in 
these patients often shows no abnormalities (Fig. 1). The 
mean duration of symptoms before diagnosis was 15 
months (1 to 72 months). The most common symptoms 
were shortness of breath (n = 28; 72%), wheeze (n = 15; 
39%), cough (n = 9; 23%), stridor (n = 8; 21%), and 
hemoptysis (n = 7; 18%). Many patients had two or more 
symptoms. In many instances, symptoms of upper airway 
obstruction (dyspnea nd wheeze) resulted in an incorrect 
diagnosis of asthma or bronchitis. 
All patients were evaluated with chest roentgenography 
and bronchoscopy, including use of a rigid bronchoscope 
and measurement of the extent of tumor involvement. In 
13 patients seen before 1980, tomograms and contrast 
tracheograms were used. After 1980, patients were exam- 
ined with computed tomograms. No patient had evidence 
of distant metastasis at the time of initial diagnosis or 
treatment. 
In 36 of 38 patients the tumor arose in the trachea with 
extension into the cricoid level or subglottic region and 
within the cricoid ring (n = 6), larynx (n = 4), or carina 
Fig. 1. Chest radiograph of patient with 5 cm tracheal 
lesion extending into the carina and left main bronchus. 
This x-ray film was interpreted as showing no abnormali- 
ties. 
(n = 13). Two patients had isolated involvement of the 
main bronchus when first examined. 
Methods of treatment for these 38 patients are summa- 
rized in Table I. 
Primary resection. Thirty-four patients underwent 37 
resections. Thirty-two patients were treated by primary 
resection with the expectation f complete resection of 
the primary tumor as initial therapy. In 29 of these 
patients the trachea was reconstructed with a primary 
anastomosis and in three patients a Marlex mesh prosthe- 
sis (Bard Implants, Billerica, Mass.) was used. 
Three of the 32 patients undergoing resection had a 
local recurrence and were reoperated on for recurrent 
disease at 2, 6, and 16 years; a primary anastomosis was done 
in two and a Marlex mesh prosthesis was used in one. 
Marlex mesh prosthesis. A cylinder of Marlex mesh was 
used for reconstruction in a total of ive patients. 1° Four of 
these five patients were operated on between 1963 and 
1967, before the techniques of extended resection were 
known. Before 1968, it was generally believed that no 
more than 3 cm of trachea could be resected and still 
safely reconstructed by primary anastomosis. 1° In retro- 
spect, three of the five patients (tumor involving an 
extensive length of trachea only) could now undergo 
primary anastomosis; a fourth patient required resection 
of a long segment of the trachea, the carina, and right 
main bronchus including the right upper lobe. The fifth 
patient in whom a Marlex prosthesis was used had an 
extensive local recurrence in the trachea nd larynx after 
primary resection and adjuvant postoperative radiother- 
apy. A second operation in this patient consisted of 
laryngectomy and resection of the entire trachea, esoph- 
agectomy with gastric replacement, and reconstruction of
the airway with a cylinder of Marlex mesh. This prosthesis 
was secured to the main carina inferiorly and sutured to 
skin as an end-tracheostomy above. 
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Preoperative management. Before resection, 12 patients 
required airway stabilization with debridement of the 
airway by use of a biopsy forceps through a rigid broncho- 
scope (n = 7), laser coagulation (n = 3), or both (n = 2). 
One patient required a temporary tracheostomy. 
Anesthesia. All 37 resections were managed by intuba- 
tion and intermittent ventilation of the distal transected 
airway. No patient required cardiopulmonary b pass. Al- 
though jet ventilation was an option, it was not used in our 
patients. If the position of the tumor permitted, the distal 
trachea was intubated, and both lungs were ventilated 
simultaneously after transection of the trachea below the 
tumor. In patients with low tracheal or carinal tumors, it 
was necessary to intubate ach side of the distal bronchial 
tree separately and independently. (A detailed escription 
of the techniques of anesthesia for carinal resection was 
reported in an earlier publicationJ l) The principles of 
anesthetic management for carinal resection are summa- 
rized as follows: Once the airway was divided below the 
lesion, each lung could be independently ventilated 
through the distal bronchial stumpsJ 1 With this tech- 
nique, it is possible to achieve good ventilation, even 
through ashort stump of relatively small diameter, such as 
the bronchus intermedius. In most cases, anesthesia was 
maintained through cuffed armored endotracheal tubes 
attached with sterile connections across the operative 
field. All patients were extubated as soon as possible after 
completion of the operation to minimize impairment of 
the circulation at the level of the anastomosis by the 
inflated cuff of the orotracheal tube. Early extubation in 
the operating room or recovery room was achieved in 32 
of 37 resections. Five patients required assisted ventilation 
for 2 to 14 days after the operation. 
Operative xposure. The 32 patients undergoing resec- 
tion were operated on by means of a variety of exposures, 
depending on the location of the primary tumor. A 
cervical collar incision was used in 11 patients and had to 
be extended to obtain adequate xposure in four of the 11 
(median sternotomy, n = 3; left thoracotomy, n = 1). 
Fourteen patients were operated on by means of only a 
median sternotomy, and 11 patients were treated by a high 
posterolateral thoracotomy (right, n = 9; left, n -- 2). One 
patient had an esophagectomy with a gastric replacement 
in addition to the tracheal resection. 
Types of resection. Primary resection of the airway was 
performed with the objective to remove all gross and 
microscopic tumor. The segment resected varied consid- 
erably in length, from 3 to 8 cm. There were 12 carinal 
resections, nine of which required the additional resection 
of some lung: sleeve resection of the right upper lobe in 
five, left pneumonectomy in two, sleeve lobectomy of the 
right upper and middle lobes in one, and right pneumo- 
nectomy in one. In the two patients requiring a left 
pneumonectomy, a normal left lung was sacrificed be- 
cause the extent of trachea and left main bronchus 
resected made it impossible to perform a primary anasto- 
mosis between the stump of the remaining left main 
bronchus and either the trachea above or the bronchus 
intermedius on the right side. 
In four cases the tumor extended superiorly to involve 
the airway within the cricoid ring. In these four patients, 
subglottic resections were done with partial cricoid resec- 
tion and thyrotracheal nastomosis, with preservation of the 
larynx and recurrent laryngeal nerves. In three patients 
laryngeal extension required laryngectomy and end-trache- 
ostomy in addition to resection of the tracheal segment. In 
two patients the tumor was confined to a main stem bron- 
chus and was resected by left pneumonectomy in one and a 
right middle and lower sleeve lobectomy in the other. 
Release procedures were performed in 20 patients to 
reduce tension at the anastomosis, lntrapericardial re- 
lease of the pulmonary hilum was done in 15 patients: 
right hila in eight and both left and right hila in seven. A 
hilar release is performed by dividing the inferior pulmo- 
nary ligament and then mobilizing the pulmonary hilum 
by incision of the pericardium and its reflections around 
the pulmonary veins and the main pulmonary artery. On 
the right side, hilar release requires the additional division 
of an intrapericardial septum that joins the lateral aspect 
of the atrium and inferior vena cava to the pericardium. 
On the left side, the ductus arteriosus must be divided to 
allow the hilum to shift upward. Superior laryngeal re- 
leases were used in seven patients: thryrohyoid release as 
described by Dedo and Fishman a2 in three, and suprahy- 
old release as described by Montgomery 13in four. 
Pathology of resected tumors. A wide resection of the 
tumor margins is almost always limited on the lateral 
surfaces of the tumor because of the proximity of vital 
structures such as the esophagus, uperior vena cava, and 
great vessels. However, margins could always be evaluated 
microscopically at the transected ends of the airway. A 
complete resection is defined as a case in which all grossly 
visible and palpable tumor was removed and the airway 
margins were reported to be histologically free of tumor at 
final pathologic examination. An incomplete resection is 
one in which any of the airway margins were reported to 
show residual tumor in the final pathologic examination. 
Intraoperative frozen section was used in every case to 
evaluate lines of transection of the airway. Microscopic 
tumor always extended beyond the gross limits of visible 
or palpable tumor, and such spread continued for 1 cm or 
more in many cases (see Figs. 2 and 3). 
Primary radiotherapy. Six patients were judged to have 
unresectable sions because of the extent of the airway 
involved. They were treated with primary radiotherapy. 
The dosage given varied between 5000 and 7500 cGy. One 
of the six patients was unable to complete the recom- 
mended course because of symptomatic bifrontal menin- 
giomas that ultimately necessitated resection. Two of 
these six patients were subsequently operated on for local 
recurrence of the tumor 7 and 8 years after irradiation. 
One of these two patients had airway obstruction and 
underwent an 8 cm tracheal resection and reconstruction 
with a Marlex mesh prosthesis. A second patient with local 
recurrence had a tracheoesophageal fistula and under- 
went an esophagectomy with gastric replacement and 
tracheostomy. This operation closed the fistula, but 2 
years later a total laryngectomy was done for control of 
disabling aspiration. 
Results 
Mortality. Three patients died within 30 days of 
the operation (9%) (see Table II). One patient, 
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treated by prosthetic reconstruction, died2 weeks 
after the operation of a trachea-innominate rtery 
fistula caused by erosion of the artery by the Marlex 
mesh prosthesis. A second eath followed resection 
of the trachea nd carina, including a right upper 
sleeve lobectomy, again reconstructed with a Marlex 
mesh prosthesis. This patient died on postoperative 
day 10 after dehiscence at the lower end of the 
prosthesis, bronchopneumonia, and cardiac arrest. 
A third patient had a cardiac arrest caused by 
presumed pulmonary embolism after resection of 
the trachea, carina, and left lung. This young man 
never regained consciousness and died 5 days later 
with bronchopneumonia and hypoxia. The embolus 
was thought o have originated in the left innomi- 
nate vein, which was stretched and traumatized 
during the operation. 
Morbidity. Complications are summarized inTa- 
ble II. Recurrent nerve palsy occurred in nine 
patients, transient in five and permanent in four. In 
the four patients who had a permanent unilateral 
recurrent nerve palsy, the nerve was deliberately 
divided at the time of the resection because of 
tumor involvement. Granulation tissue at the anas- 
tomosis complicated the course of eight patients but 
was easily managed with bronchoscopy and local 
debridement. No patient required reintubation be- 
cause of obstruction owing to granulation tissue. 
There were five wound infections. Two of the five 
occurred in collar incisions and one in a median 
sternotomy. These three patients were treated lo- 
cally and with antibiotics. The remaining two infec- 
tions occurred after dehiscence of a right thoracot- 
omy and of a sternotomy. Both patients required 
operative closure of the dehiscence. 
Dysphagia occurred in four patients. All four had 
superior release procedures added to the recon- 
struction. In all but one of these four patients, the 
dysphagia was temporary. The patient with perma- 
nent dysphagia received radical postoperative radio- 
therapy (6200 cGy), which resulted in a radiation- 
induced esophageal stricture and permanent 
obstruction to swallowing. 
Although stenosis occurred in three patients, only 
one of them required reoperation and revision of 
the tracheal anastomosis. The other two patients 
had a benign anastomotic stricture after carinal 
resection and were satisfactorily treated by dilata- 
tion. Miscellaneous complications include broncho- 
pneumonia (n = 2), temporary tracheostomy (n = 
2), wound dehiscence (n = 1), and an esophageal 
fistula after esophagectomy (n = 1). 
Fig. 2. Gross appearance of a resected specimen of ade- 
noid cystic carcinoma. The overlying mucosa is intact and 
the gross margins of the tumor appear circumscribed. 
Survival data. Follow-up data were complete in 
all 38 patients. Survival was calculated by the 
Kaplan-Meier actuarial method. Survival curves 
were compared by means of the log-rank test. 
Continuous data were analyzed by two-tailed t tests 
and expressed as the mean _+ standard eviation. 
Statistically significant difference is defined as a p 
value -< 0.05. 
Survival data are summarized in Table III. Mean 
survival for the entire group of 38 patients was 85 
months (5 days to 29 years). Twenty-five of these 38 
patients are dead. There were three operative 
deaths. Thirteen deaths were due to adenoid cystic 
carcinoma, from either hematogenous metastasis 
(n = 5) or local recurrence (n = 8). An additional 
two deaths were due to unrelated isease in patients 
who had known clinical recurrence of the primary 
tumor. Seven patients died of unrelated isease and 
appeared to be clinically free of tumor at the time of 
death. 
Primary resection. Thirty-two patients were 
treated by primary resection with a mean survival of 
85 + 89 months (5 days to 352 months). These data 
are expressed as actuarial survival in Fig. 4: 79% at 
5 years and 51% at 10 years. According to the 
log-rank test, these survival curves showed no sta- 
tistically significant difference. 
The 32 patients undergoing resection were di- 
vided into two groups: 16 patients undergoing pre- 
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Fig. 3. A, Photomicrograph illustrating the extensive microscopic spread of adenoid cystic carcinoma. The 
spread occurs both longitudinally and circumferentially and is neither visible to nor palpable by the 
operating surgeon. Tr, Trachea. B, Photomicrograph illustrating adenoid cystic carcinoma, spreading 
longitudinally on the outer surface of the trachea, in the perineural lymphatic spaces. 
Table II. Complications of surgical resections 
No. of 
patients 
Operative mortality (30-day) 3 
Trachea-innominate artery fistula 1 
(Marlex mesh) 
Airway dehiscence, pneumonia (Marlex 1 
mesh) 
Pneumonia, cerebral hypoxia (possible 1 
pulmonary embolus) 
Morbidity 22 
Recurrent nerve palsy 9 
Airway granulation 8 
Wound infection 5 
Dysphagia 4 
Stenosis 3 
Miscellaneous 6 
Table III. Survival data for 38 patients with 
adenoid cystic carcinoma 
Mean Median 
No. of survival survival 
patients (mo) (mo) 
Overall 
Primary resection 
Complete resection, 
disease-free margins 
Incomplete resection, 
diseased margins 
Primary radiotherapy 
16 
16 
38 85 60 
32 87* 73* 
118? 93f 
90~ 61~ 
6 74§ 87§ 
*Survival in 29 patients excluding three operative d aths. 
?Survival in 14 patients excluding two operative d aths. 
+Survival in15 patients excluding one operative death. 
§Two of six patients who had primary radiotherapy later underwent 
resection for local recurrence in the airway. 
sumably complete resection in whom the resection 
margins were histologically free of disease on final 
pathologic examination and 16 patients in whom the 
final resection margins contained residual tumor. 
There were two postoperative deaths in the 16 
patients with presumably complete resection, and 
mean survival in the 14 remaining patients was 
118 _+ 105 months (12 to 352 months). In the 16 
patients with incomplete resection (residual tumor 
at the resection margins on final pathologic exami- 
nation), there was one operative death, and mean 
survival in the remaining 15 patients was 90 _+ 75 
months (4 to 254 months). These urvival data are 
presented as actuarial survival curves in Fig. 5. Al- 
though the survival differences do not reach sta- 
tistical significance according to the log-rank test, 
there is a trend for increased survival in the group 
undergoing complete resection, particularly at 10 
years: complete resection 69%, incomplete 30%. 
Primary radiotherapy. Six patients had tumors that 
were judged to be unresectable, and they were 
treated primarily with radical radiotherapy. The 
mean survival in these six patients was 74 + 64 
months (1 to 172). Two of these six patients ulti- 
mately had airway obstruction as a result of local 
recurrence and were operated on 7 and 8 years after 
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Fig. 4. Actuarial survival curve in 32 patients treated by primary resection. Because of three operative 
deaths, 29 patients were at risk. 
initial radiation. In both cases a palliative operation 
was done, with known residual tumor remaining 
after the procedure. These two patients urvived for 
33 and 25 months, respectively, after surgical resec- 
tion. 
Adjuvant radiotherapy. Twenty-five of the 32 pa- 
tients undergoing resection received adjuvant radio- 
therapy: postoperative radiation, n = 16; preopera- 
tive radiation, n = 9. In the group of patients 
receiving adjuvant radiation (23 patients excluding 
two operative deaths), the mean survival was 88 _+ 
76 months (11 to 263 months). Six of the seven 
patients who had no adjuvant radiotherapy had had 
complete resection. There was one operative death 
in the group of seven patients who did not receive 
any adjuvant radiotherapy. Mean survival in the six 
remaining patients was 131 _+ 131 months (5 to 352 
months). There was no significant difference in 
mean survival between these two categories. 
Influence of metastatic tumor. The incidence of 
metachronous hematogenous metastasis summa- 
rized in Table IV. No patient had clinically identi- 
fied hematogenous metastases at the time of initial 
or primary treatment. Hematogenous metastases 
were identified during follow-up in 17 of the 38 
patients. In 13 of these 17 patients, pulmonary 
metastases were present, and seven of the 13 pa- 
tients with pulmonary spread had no documented 
metastasis at other sites. After initial therapy, this 
group of 17 patients remained clinically free of 
disease for a mean of 100 _+ 79 months (12 to 300 
months). After the recognition of metastatic dis- 
ease, mean survival continued for an additional 37 _+ 
26 months (4 to 84 months). Pulmonary metastases 
often remained asymptomatic for long periods. Two 
patients with pulmonary metastasis were treated 
with combination chemotherapy without any observ- 
able clinical response. 
Metastatic tumor was identified in the regional 
lymph nodes of five patients. These five patients had 
a mean survival of 42 +_ 46 months (4 to 120 
months). In contrast, those patients without docu- 
mented lymph node involvement survived for a 
mean of 111 _+ 91 months (12 to 348 months) (p = 
0.11). Spread in the perineural lymphatic spaces was 
seen in eight patients who had a mean survival of 
71 _+ 70 months (12 to 233 months). There was no 
statistically significant difference in survival between 
patients with and without perineural lymphatic 
spread. 
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Fig. 5. Actuarial survival curve comparing the results of complete and incomplete r section. Dashed line, 
Complete resection (15 patients at risk); solid line, incomplete r section (14 patients at risk). 
Table IV. Sites of  metastases in 17patients 
Site No. 
Pulmonary 13 
Liver 4 
Bone 3 
Brain 2 
Renal 1 
Heart 1 
Skin 1 
Abdomen 1 
Local recurrence. Local recurrence of the primary 
tumor in the airway was documented in eight of 38 
patients. Only three of these local recurrences oc- 
curred in the 32 patients treated by primary resec- 
tion. In contrast, five of the six patients treated with 
primary radiotherapy had local recurrence, which 
was the ultimate cause of death in all five. 
The interval between primary treatment and doc- 
umented local recurrence may be of astonishing 
duration (see Figs. 6 to 8). The mean disease-free 
interval before local recurrence in these eight pa- 
tients was 88 months (4 to 324 months). After 
clinical recognition of local recurrence, the mean 
survival was 33 months (4 to 81 months). Seven of 
the eight patients with local recurrence also had 
hematogenous metastasis during the period of 
follow-up. 
Discuss ion 
Adenoid cystic carcinoma is a rare primary tumor 
of the upper airway, which is frequently amenable to 
resection and reconstruction by primary anastomo- 
sis. At present, such surgery can be accomplished 
with a reasonably low operative mortality rate and 
remarkably good long-term survival, particularly if
survival is compared with that observed with the 
more common primary lung cancers. Our reported 
results are summarized in Table V and compared 
with observations reported in previous publications 
by Grillo and Mathisen, 2 Perelman and Koroleva, 7
and Regnard and associates. 9 Long periods of fol- 
low-up were obtained in all four of these reports: 20, 
23, 26, and 32 years. Operative mortality was close 
to 10% in three of the four reports in which 
operative mortality was specifically identified. Most 
important, actuarial 5- and 10-year survivals, calcu- 
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Fig. 6. Tumor in the upper mediastinal trachea of a 
15-year-old girl. The tumor was resected and replaced 
with a cylinder of Marlex mesh in 1963. 
lated by the Kaplan-Meier method, were between 
65% and 79% at 5 years and between 53% and 57% 
at 10 years. 
Although the objective in resectable cases is to 
obtain a complete and potentially curative opera- 
tion, it is frequently impossible to safely extend the 
resection far enough to obtain histologically disease- 
free margins at the transected ends of the airway. It 
is again worthy of emphasis that adenoid cystic 
tumors of the upper airway frequently spread 1 cm 
or more beyond the palpable and visible confines of 
the neoplasm. This determination can be made only 
during the operation by means of frozen section 
assessment to evaluate the resection margins. At this 
stage in the operation, the gross tumor has already 
been resected, and the surgeon is faced with the 
options of either leaving tumor at the resection 
margin or further extending the resection, which 
may be incompatible with a safe reconstruction by
primary anastomosis. In our series, there were 16 
patients who were treated primarily by resection in 
whom the final resection margins contained residual 
tumor. These patients had a mean survival of 90 
months after an incomplete operation. This is not 
greatly different from the survival observed in 16 
Fig. 7. A contrast tracheogram in the sam  patient, 4 
years after prosthetic replacement. The prosthetic ai way 
is indicated by the black arrow and is widely patent. 
Beginning at 41/2 years, progressive narrowing developed 
at the upper nds of the prosthesis. 
patients with complete resections and negative mar- 
gins at final pathologic examination, who had a 
mean survival of 119 months. The numbers in each 
group are small, and there is no statistically signifi- 
cant difference in these survival data. Furthermore, 
only three instances of local recurrence were docu- 
mented in the patients treated by primary resection. 
These observations suggest that an incomplete re- 
section, in which the gross tumor is entirely removed 
but microscopic disease remains at the margins, may 
still provide the best treatment, or palliation, in 
selected patients. 
Six patients in this report were treated primarily 
with radical radiation therapy. In some of them long 
periods of remission were obtained, ranging be- 
tween 1 and 172 months, with a mean survival of 74 
months. However, five of these six patients ulti- 
mately had a fatal local recurrence. 
The role of adjuvant radiotherapy is impossible to 
evaluate with any certainty. Adjuvant radiation in a 
variety of dosages was used in 25 of the 32 patients 
managed by primary resection. There was, however, 
no statistically significant difference in survival be- 
tween the 25 patients receiving adjuvant radiation 
and the seven patients who did not. It appears 
logical, nevertheless, to assume that adjuvant radio- 
therapy may be beneficial and likely to delay or 
reduce the incidence of local recurrence in the 
airway. 
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Fig. 8. A, In 1968, 5 years after the initial resection, the patient was again operated on. The prosthesis and 
adjacent tracheal ends were resected. B, The airway was reconstructed by primary anastomosis. Release 
procedures were used at the upper and lower ends of the airway. 
Table V. Reported results of resection for adenoid cystic carcinoma of the airway 
Grillo 2 Perelman 7 Regnard 9 Pearson 
No. of patients 60 
Years of follow-up 26 
Operative mortality 8 (13%) 
Actuarial survival (%) 
5 yr 
10 yr 
Mean survival (mo) 
Radiation only 39 
Resection and radiation 108 
56 65 38 
20 23 32 
8 (14%) 3 (9%) 
66 73 79 
56 57 51 
74 
88 
Hematogenous metastases occurred in more than 
half of our patients, and by far the commonest site 
of metastatic disease was the lungs. However, these 
metastases often occur long after initial diagnosis of 
the primary tumor (12 to 300 months with a mean 
interval of 100 months). Furthermore, these patients 
survived for as long as 7 years after the diagnosis of 
hematogenous spread, with a mean survival interval 
of 3 years (37 months). To date, there is no evidence 
that chemotherapy is useful in the management of
these metastases. Lymphatic metastases are rela- 
tively uncommon and did not significantly alter 
survival in the small number of cases reported here. 
In summary, adenoid cystic carcinoma of the 
upper airway is a rare primary tumor that occurs in 
all adult age groups and is frequently slow to 
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progress and late to metastasize or recur locally. 
Many cases are amenable  to a segmental  resect ion 
of the airway with removal  of all gross disease and 
reconstruct ion by pr imary anastomosis.  Most  tu- 
mors will respond to radiotherapy,  which often 
results in long per iods of remission in patients 
t reated with rad iotherapy alone. Given the l imita- 
tions of this nonrandomized comparison, f rom our 
review it seems reasonable to recommend adjuvant 
rad iotherapy in all patients undergoing resection, 
and certainly in those patients in whom the final 
pathologic examinat ion identif ies residual tumor  at 
the resect ion margins. Both complete and incom- 
plete resections can be done with an acceptably low 
operat ive mortal i ty and with the expectat ion of long 
per iods of survival in a major i ty of patients. 
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Discussion 
Dr. Douglas E. Wood (Seattle, Wash.). I compliment Dr. 
Maziak, Dr. Pearson, and their colleagues for an excellent 
review of a rare tumor. Dr. Pearson is one of the world 
leaders in the development of indications and techniques 
for airway surgery and presented one of the earliest 
experiences of adenoid cystic carcinoma of the trachea in 
1974 and of other primary tumors of the trachea in 1984 
at this Association. Dr. Maziak is to be especially com- 
mended for achieving 100% follow-up in these patients 
accrued over a 32-year period. 
I would like to emphasize two points from this paper. 
Adenoid cystic carcinoma of the trachea has a protracted 
natural history with patients, recurring up to 29 years after 
tracheal resection. These patients can have excellent 
palliation with a combination of surgery and radiation. 
Microscopically diseased margins and diseased regional 
lymph nodes appear to have a minimal effect on survival in 
this series, as well as the series published by Grillo and 
Mathisen. Even patients with metastatic disease have a 
mean survival of 3 years and therefore require aggressive 
treatment for their tracheal primary tumor to provide 
palliation. 
Reports on alternative therapies for adenoid cystic 
carcinoma, namely, radiation therapy, usually present 
5-year data; however, they need to present similar lengths 
of follow-up as well as diligence in surveillance to compare 
with the surgical results from Toronto and elsewhere. As 
surgeons, we may underestimate the effectiveness of radi- 
ation and unfairly compare it with surgery when we refer 
patients with the more advanced, unresectable tumors to 
the radiation oncologists. We must be cautious not to 
draw conclusions regarding the efficacy of different reat- 
ment modalities in these retrospective nonrandomized 
reports. 
I have three questions for Dr. Maziak. Neutron beam 
irradiation provides a threefold increase over photons in 
local/regional control of adenoid cystic carcinoma of the 
head and neck. Should patients with tracheal adenoid 
cystic carcinoma undergo surgical resection followed by 
neutron rather than photon adjuvant therapy, or perhaps 
should these patients even be referred for primary neu- 
tron beam irradiation? 
You described five patients with a Marlex mesh pros- 
thesis for reconstruction of the trachea. What were the 
long-term results in this group of patients, and is this a 
technique that you would still consider for extensive 
tracheal tumors? 
Finally, could tracheal homografts be used in adults to 
achieve a more radical resection, and do you think that 
this might provide an increase in survival? 
Dr. Maziak. Thank you for your comments, Dr. Wood. 
The first question posed is about different forms of 
radiation. All of our patients received photon radiation 
supervised by the radiotherapists. Whether neutron beam 
irradiation would be preferable I cannot comment. 
With regard to the five patients in this series (adenoid 
cystic carcinoma of the airway) who had the Marlex mesh 
prosthesis reconstruction, two died of complications 
within 30 days relating to the Marlex prosthesis; trachea- 
innominate artery fistula in one and carinal dehiscence in
the other. The other three patients had good long-term 
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palliation with the prothesis: 2years, 5 years, and 8 years. 
Three of the five operations were done before 1967 and 
knowledge of the current echniques for extended resec- 
tion were not known. In retrospect, hese three tracheal 
tumors could now be reconstructed byprimary anastomo- 
sis. At present here is rarely if ever an indication for 
prosthetic replacement. A majority of cases that might 
warrant tracheal replacement beyond the limits which can 
be managed by primary anastomosis are technically inop- 
erable. 
Dr. Wood also asked about the role of tracheal ho- 
mograft. That would require preservation of a strip of the 
host membranous trachea. This will rarely be possible in 
patients with extensive tracheal neoplasms and has yet to 
be used as a means of long-term tracheal reconstruction. 
Dr. Hermes C. Grillo (Boston, Mass.). The Toronto 
group provided what we really need in looking at this 
disease, namely, some long-term data. 
I will just make an amplifying comment or two. You 
have the figures from the French series, in which there 
were 65 resections from 26 different institutions. I had a 
recent communication from Professor Perelman in Mos- 
cow, who has been at this for 31 years, as have you and we. 
His group has a total now of 66 patients and 50 resections, 
which is about a 76% resectability rate. This is close to our 
resectability rate for this particular tumor, in contrast to 
squamous tracheal cancer, for which it is about 66%. 
Bryan Meyers is currently reviewing our cases at Massa- 
chusetts General Hospital. Of 103 patients, only 75 were 
operated on, about a 73% resection rate. Survival, and I 
hesitate to mention it because it is very preliminary, seems 
to be about 79% at 5 years and about 42% at 10 years. So 
it is a disease that keeps recurring. It is very unlike 
squamous cancer of the trachea, which behaves like lung 
cancer in terms of recurrence. If we add the figures from 
Canada, Russia, France, and the United States, from 
these major series, we find about 220 resected cases of 
adenocarcinoma in 30 years, which shows how hard it is to 
accumulate data. We are just beginning now to collect 
enough data to say what the clinical pattern is. What is 
clear is that we are all coming out with about the same 
findings. 
In our 75 resected cases there were three staged 
resections, which we no longer do, and ten laryngecto- 
mies. Among the patients who underwent resection with 
reconstruction, there were 26 lesions in the trachea nd 36 
in the carina. Twenty were in the carina alone, six 
necessitated removal of the right upper lobe, and 10 
necessitated pneumonectomy, usually left pneumonec- 
tomy, with carina. I wonder if you saw the same amazing 
frequency in the carinal evel, which requires the most 
complicated resections, with the highest mortality rate. 
Dr. Maziak. Thank you for your kind comments Dr. 
Grillo. In 36 of 38 patients the tumor arose in the 
trachea, with extension into the cricoid or subglottic 
level in six, larynx in four, and carina in 13. Among the 
32 patients who underwent primary resection of the 
airway, there were 12 carinal resections, nine of which 
required additional resection of lung: sleeve resection 
of the right upper lobe (5), left pneumonectomy (2), 
sleeve lobectomy of the right upper and middle lobes 
(1), and right pneumonectomy (1). In the two patients 
requiring left pneumonectomy, a normal eft lung was 
sacrificed because it was impossible to perform a pri- 
mary anastomosis. Two of our three operative deaths 
followed carinal resection. 
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